المؤلفون: Asadian, M., Zabihi, F., Saeedi, H.

المصدر: Journal of Crystal Growth ; volume 630, page 127605 ; ISSN 0022-0248

الاتاحة: http://dx.doi.org/10.1016/j.jcrysgro.2024.127605
https://api.elsevier.com/content/article/PII:S002202482400040X?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S002202482400040X?httpAccept=text/plain

المؤلفون: Douraghi, M, Kenyon, JJ, Aris, P, Asadian, M, Ghourchian, S, Hamidian, M

وصف الملف: Electronic; application/pdf

Relation: mSphere; mSphere, 2020, 5, (2); http://hdl.handle.net/10453/142156

الاتاحة: http://hdl.handle.net/10453/142156

المؤلفون: Hamdi, Z., Momeni, M. S., Meyghani, B., Zivar, D., Chung, B. Y., Bataee, M., Asadian, M. A.

المصدر: Hamdi , Z , Momeni , M S , Meyghani , B , Zivar , D , Chung , B Y , Bataee , M & Asadian , M A 2019 , ' Oil well compressive strength analysis from sonic log; A case study ' , IOP Conference Series: Materials Science and Engineering , vol. 495 , no. 1 , 012077 . https://doi.org/10.1088/1757-899X/495/1/012077

Relation: https://pure.au.dk/portal/en/publications/5d93191e-23e7-4f41-aea3-e502884ff803

الاتاحة: https://pure.au.dk/portal/en/publications/5d93191e-23e7-4f41-aea3-e502884ff803
https://doi.org/10.1088/1757-899X/495/1/012077
http://www.scopus.com/inward/record.url?scp=85067835169&partnerID=8YFLogxK

المؤلفون: Azimi, L, Alaghehbandan, R, Asadian, M, Alinejad, F, Lari, AR

المصدر: GMS Hygiene and Infection Control; VOL: 14; DOC01 /20190122/

مصطلحات موضوعية: health care-associated infection, P. aeruginosa, K. pneumoniae, antibiotic resistance, genetic relationship, pulsed-field gel electrophoresis, nosokomiale Infektion, Antibiotikaresistenz, genetische Verwandtschaft, Pulsfeld-Gel-Elektrophorese, ddc: 610

Relation: Alaghehbandan R, Azimi L, Rastegar Lari A. Nosocomial infections among burn patients in Teheran, Iran: a decade later. Ann Burns Fire Disasters. 2012 Mar 31;25(1):3-7.; Azimi L, Motevallian A, Ebrahimzadeh Namvar A, Asghari B, Lari AR. Nosocomial infections in burned patients in motahari hospital, tehran, iran. Dermatol Res Pract. 2011;2011:436952. DOI:10.1155/2011/436952; Azimi L, Nordmann P, Lari AR, Bonnin RA. First report of OXA-48-producing Klebsiella pneumoniae strains in Iran. GMS Hyg Infect Control. 2014 Mar 7;9(1):Doc07. DOI:10.3205/dgkh000227; Azimi L, Talebi M, Pourshafie MR, Owlia P, Rastegar Lari A. Characterization of Carbapenemases in Extensively Drug Resistance Acinetobacter baumannii in a Burn Care Center in Iran. Int J Mol Cell Med. 2015;4(1):46-53.; Azimi L, Talebi M, Owlia P, Rastegar-Lari A. Investigated of ampC in Carbapenem Resistant Gram-Negative Bacteria Isolated from Burned Patients. J Med Bacteriol. 2014;3(3-4):20-5.; Beheshti S, Zia M. Bacteriology of burns and antibiogram in an Iranian burn care center. Afr J Pharm Pharmacol. 2011;5(4):538-41. DOI:10.5897/AJPP10.375; Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: nineteenth informational supplement M100-S21. Wayne, PA: CLSI; 2013.; Fazeli H, Akbari R, Moghim S, Narimani T, Arabestani MR, Ghoddousi AR. Pseudomonas aeruginosa infections in patients, hospital means, and personnel's specimens. J Res Med Sci. 2012 Apr;17(4):332-7.; Finnan S, Morrissey JP, O'Gara F, Boyd EF. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment. J Clin Microbiol. 2004 Dec;42(12):5783-92. DOI:10.1128/JCM.42.12.5783-5792.2004; Lanini S, D'Arezzo S, Puro V, Martini L, Imperi F, Piselli P, Montanaro M, Paoletti S, Visca P, Ippolito G. Molecular epidemiology of a Pseudomonas aeruginosa hospital outbreak driven by a contaminated disinfectant-soapdispenser. PLoS One. 2011 Feb 16;6(2):e17064. DOI:10.1371/journal.pone.0017064; Lari AR, Alaghehbandan R. Nosocomial infections in an Iranian burn care center. Burns. 2000 Dec;26(8):737-40. DOI:10.1016/S0305-4179(00)00048-6; Lari AR, Azimi L, Soroush S, Taherikalani M. Low prevalence of metallo-beta-lactamase in Pseudomonas aeruginosa isolated from a tertiary burn care center in Tehran. Int J Immunopathol Pharmacol. 2015 Sep;28(3):384-9. DOI:10.1177/0394632015578343; Naze F, Jouen E, Randriamahazo RT, Simac C, Laurent P, Blériot A, Chiroleu F, Gagnevin L, Pruvost O, Michault A. Pseudomonas aeruginosa outbreak linked to mineral water bottles in a neonatal intensive care unit: fast typing by use of high-resolution melting analysis of a variable-number tandem-repeat locus. J Clin Microbiol. 2010 Sep;48(9):3146-52. DOI:10.1128/JCM.00402-10; Petit SM, Lavenir R, Colinon-Dupuich C, Boukerb AM, Cholley P, Bertrand X, Freney J, Doléans-Jordheim A, Nazaret S, Laurent F, Cournoyer B. Lagooning of wastewaters favors dissemination of clinically relevant Pseudomonas aeruginosa. Res Microbiol. 2013 Oct;164(8):856-66. DOI:10.1016/j.resmic.2013.06.007; Rastegar Lari A, Azimi L, Rahbar M, Fallah F, Alaghehbandan R. Phenotypic detection of Klebsiella pneumoniae carbapenemase among burns patients: first report from Iran. Burns. 2013 Feb;39(1):174-6. DOI:10.1016/j.burns.2012.02.025; Salimi H, Yakhchali B, Owlia P. Molecular epidemiology and drug susceptibility of Pseudomonas aeruginosa strains isolated from burn patients. Lab Med. 2010;41(9):540-4. DOI:10.1309/LMNIJE31EDC1WAMP; Salimi H, Owlia P, Yakhchali B, Martini L. Characterization of Pseudomonas aeruginosain burn patients using PCR- restriction fragment length polymorphism and random amplified polymorphic DNA analysis. Iran J Med Sci. 2010;35(3):236-41.; Tofteland S, Naseer U, Lislevand JH, Sundsfjord A, Samuelsen O. A long-term low-frequency hospital outbreak of KPC-producing Klebsiella pneumoniae involving Intergenus plasmid diffusion and a persisting environmental reservoir. PLoS ONE. 2013;8(3):e59015. DOI:10.1371/journal.pone.0059015; Voulgari E, Zarkotou O, Ranellou K, Karageorgopoulos DE, Vrioni G, Mamali V, Themeli-Digalaki K, Tsakris A. Outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in Greece involving an ST11 clone. J Antimicrob Chemother. 2013 Jan;68(1):84-8. DOI:10.1093/jac/dks356; Zanetti G, Blanc DS, Federli I, Raffoul W, Petignat C, Maravic P, Francioli P, Berger MM. Importation of Acinetobacter baumannii into a burn unit: a recurrent outbreak of infection associated with widespread environmental contamination. Infect Control Hosp Epidemiol. 2007 Jun;28(6):723-5. DOI:10.1086/517956; http://dx.doi.org/10.3205/dgkh000317; http://nbn-resolving.de/urn:nbn:de:0183-dgkh0003173; http://www.egms.de/en/journals/dgkh/2019-14/dgkh000317.shtml

الاتاحة: https://doi.org/10.3205/dgkh000317
http://nbn-resolving.de/urn:nbn:de:0183-dgkh0003173
http://www.egms.de/en/journals/dgkh/2019-14/dgkh000317.shtml

المؤلفون: Valadan Tahbaz, S, Azimi, L, Asadian, M, Lari, AR

المصدر: GMS Hygiene and Infection Control; VOL: 14; DOC08 /20190802/

مصطلحات موضوعية: Acinetobacter baumannii, tazobactam, MIC, carbapenem resistance, Carbapenemeresistenz, ddc: 610

Relation: An JH, Kim YH, Moon JE, Jeong JH, Kim SH, Kang SJ, Park KH, Jung SI, Jang HC. Active surveillance for carbapenem-resistant Acinetobacter baumannii in a medical intensive care unit: Can it predict and reduce subsequent infections and the use of colistin? Am J Infect Control. 2017 Jun;45(6):667-72. DOI:10.1016/j.ajic.2017.01.016; Barnaud G, Zihoune N, Ricard JD, Hippeaux MC, Eveillard M, Dreyfuss D, Branger C. Two sequential outbreaks caused by multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 or OXA-72 oxacillinase in an intensive care unit in France. J Hosp Infect. 2010 Dec;76(4):358-60. DOI:10.1016/j.jhin.2010.05.026; Chagas TP, Carvalho KR, de Oliveira Santos IC, Carvalho-Assef AP, Asensi MD. Characterization of carbapenem-resistant Acinetobacter baumannii in Brazil (2008-2011): countrywide spread of OXA-23-producing clones (CC15 and CC79). Diagn Microbiol Infect Dis. 2014 Aug;79(4):468-72. DOI:10.1016/j.diagmicrobio.2014.03.006; Chen Y, Gao J, Zhang H, Ying C. Spread of the bla(OXA-23)-Containing Tn2008 in Carbapenem-Resistant Acinetobacter baumannii Isolates Grouped in CC92 from China. Front Microbiol. 2017 Feb 6;8:163. DOI:10.3389/fmicb.2017.00163; Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev. 2006 Apr;19(2):403-34. DOI:10.1128/CMR.19.2.403-434.2006; Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: nineteenth informational supplement M100-S21. 2018.; Coban YK. Infection control in severely burned patients. World J Crit Care Med. 2012 Aug;1(4):94-101. DOI:10.5492/wjccm.v1.i4.94; Codjoe FS, Donkor ES. Carbapenem Resistance: A Review. Med Sci (Basel). 2017 Dec 21;6(1):1. DOI:10.3390/medsci6010001; Deveci Ö, Dal T, Tekin R, Bozkurt F, Tekin A, Dayan S. Carbapenem resistance in Acinetobacter baumannii: where is it heading? Infez Med. 2013 Sep;21(3):211-5. DOI: 0.5455/medscience.2014.03.8124; Douraghi M, Jasemi S, Kodori M, Rahbar M, Boroumand MA. Evidence of Interruption of the comM Gene in a Large Series of Clinical Isolates of Multidrug-Resistant Acinetobacter baumannii. J Mol Microbiol Biotechnol. 2016;26(6):410-413. DOI:10.1159/000448785; de Souza Gusatti C, Bertholdo LM, Otton LM, Marchetti DP, Ferreira AE, Corção G. First occurrence of bla OXA-58 in Acinetobacter baumannii isolated from a clinical sample in Southern Brazil. Braz J Microbiol. 2012 Jan;43(1):243-6. DOI:10.1590/S1517-838220120001000027; Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005 May;40(9):1333-41. DOI:10.1086/429323; Farsiani H, Mosavat A, Soleimanpour S, Nasab MN, Salimizand H, Jamehdar SA, Ghazvini K, Aryan E, Baghani AA. Limited genetic diversity and extensive antimicrobial resistance in clinical isolates of Acinetobacter baumannii in north-east Iran. J Med Microbiol. 2015 Jul;64(7):767-73. DOI:10.1099/jmm.0.000090; Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006 Mar;42(5):692-9. DOI:10.1086/500202; Fu Y, Jiang J, Zhou H, Jiang Y, Fu Y, Yu Y, Zhou J. Characterization of a novel plasmid type and various genetic contexts of bla OXA-58 in Acinetobacter spp. from multiple cities in China. PLoS ONE. 2014;9(1):e84680. DOI:10.1371/journal.pone.0084680; Hasan B, Perveen K, Olsen B, Zahra R. Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan. J Med Microbiol. 2014 Jan;63(Pt 1):50-5. DOI:10.1099/jmm.0.063925-0; Héritier C, Poirel L, Lambert T, Nordmann P. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother. 2005 Aug;49(8):3198-202. DOI:10.1128/AAC.49.8.3198-3202.2005; Jeon BC, Jeong SH, Bae IK, Kwon SB, Lee K, Young D, Lee JH, Song JS, Lee SH. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in korea. J Clin Microbiol. 2005 May;43(5):2241-5. DOI:10.1128/JCM.43.5.2241-2245.2005; Jung SY, Lee SH, Lee SY, Yang S, Noh H, Chung EK, Lee JI. Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: a systemic review and Bayesian network meta-analysis. Crit Care. 2017 Dec;21(1):319. DOI:10.1186/s13054-017-1916-6; Kiffer CR, Sampaio JL, Sinto S, Oplustil CP, Koga PC, Arruda AC, Turner PJ, Mendes C. In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii. Diagn Microbiol Infect Dis. 2005 Aug;52(4):317-22. DOI:10.1016/j.diagmicrobio.2005.03.003; Lin MF, Lan CY. Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside. World J Clin Cases. 2014 Dec;2(12):787-814. DOI:10.12998/wjcc.v2.i12.787; Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012 Mar;18(3):268-81. DOI:10.1111/j.1469-0691.2011.03570.x; Manchanda V, Sanchaita S, Singh N. Multidrug resistant acinetobacter. J Glob Infect Dis. 2010 Sep;2(3):291-304. DOI:10.4103/0974-777X.68538; Marie MA, Krishnappa LG, Alzahrani AJ, Mubaraki MA, Alyousef AA. A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii. Bosn J Basic Med Sci. 2015 Oct;15(4):24-9. DOI:10.17305/bjbms.2015.526; Marqué S, Poirel L, Héritier C, Brisse S, Blasco MD, Filip R, Coman G, Naas T, Nordmann P. Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. J Clin Microbiol. 2005 Sep;43(9):4885-8. DOI:10.1128/JCM.43.9.4885-4888.2005; Mohammadi F, Goudarzi H, Hashemi A, Nojookambari NY, Khoshnood S, Sabzehali F. Detection of ISAba1 in Acinetobacter baumannii strains carrying OXA genes isolated from iranian burns patients. Arch Ped Infect Dis. 2017 April;5(2):e39307.; Munita JM, Arias CA. Mechanisms of Antibiotic Resistance. Microbiol Spectr. 2016 04;4(2):. DOI:10.1128/microbiolspec.VMBF-0016-2015; Nowak J, Zander E, Stefanik D, Higgins PG, Roca I, Vila J, McConnell MJ, Cisneros JM, Seifert H; MagicBullet Working Group WP4. High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial. J Antimicrob Chemother. 2017 Dec;72(12):3277-82. DOI:10.1093/jac/dkx322; Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. Carbapenems: past, present, and future. Antimicrob Agents Chemother. 2011 Nov;55(11):4943-60. DOI:10.1128/AAC.00296-11; Rezaei A, Fazeli H, Moghadampour M, Halaji M, Faghri J. Determination of antibiotic resistance pattern and prevalence of OXA-type carbapenemases among Acinetobacter baumannii clinical isolates from inpatients in Isfahan, central Iran. Infez Med. 2018 Mar;26(1):61-66.; Rynga D, Shariff M, Deb M. Phenotypic and molecular characterization of clinical isolates of Acinetobacter baumannii isolated from Delhi, India. Ann Clin Microbiol Antimicrob. 2015 Sep;14:40. DOI:10.1186/s12941-015-0101-5; Sahuquillo-Arce J, Hernández-Cabezas A, Yarad-Auad F, Ibáñez-Martínez E, Falomir-Salcedo P, Ruiz-Gaitán A. Carbapenemases: A worldwide threat to antimicrobial therapy. World J Pharmacol. 2015;4(1):75-95. DOI:10.5497/wjp.v4.i1.75; Salehi B, Goudarzi H, Nikmanesh B, Houri H, Alavi-Moghaddam M, Ghalavand Z. Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran. J Infect Chemother. 2018 Jul;24(7):515-523. DOI:10.1016/j.jiac.2018.02.009; Sirijatuphat R, Thamlikitkul V. Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections. Antimicrob Agents Chemother. 2014 Sep;58(9):5598-601. DOI:10.1128/AAC.02435-13; Sohrabi N, Farajnia S, Akhi MT, Nahaei MR, Naghili B, Peymani A, Amiri Z, Rezaee MA, Saeedi N. Prevalence of OXA-type beta-lactamases among Acinetobacter baumannii isolates from Northwest of Iran. Microb Drug Resist. 2012 Aug;18(4):385-9. DOI:10.1089/mdr.2011.0077; Taherikalani M, Fatolahzadeh B, Emaneini M, Soroush S, Feizabadi MM. Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals. New Microbiol. 2009 Jul;32(3):265-71.; Tekin R, Dal T, Bozkurt F, Deveci O, Palanc Y, Arslan E, Selçuk CT, Hosoglu S. Risk factors for nosocomial burn wound infection caused by multidrug resistant Acinetobacter baumannii. J Burn Care Res. 2014 Jan-Feb;35(1):e73-80. DOI:10.1097/BCR.0b013e31828a493f; Temocin F, Erdinc FS, Tulek N, Demirelli M, Ertem G, Kinikli S, Koksal E. Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii. Braz J Microbiol. 2015 Oct-Dec;46(4):1119-24. DOI:10.1590/S1517-838246420140101; Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, Pitt TL. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett. 2006 May;258(1):72-7. DOI:10.1111/j.1574-6968.2006.00195.x; Uwingabiye J, Lemnouer A, Roca I, Alouane T, Frikh M, Belefquih B, Bssaibis F, Maleb A, Benlahlou Y, Kassouati J, Doghmi N, Bait A, Haimeur C, Louzi L, Ibrahimi A, Vila J, Elouennass M. Clonal diversity and detection of carbapenem resistance encoding genes among multidrug-resistant isolates recovered from patients and environment in two intensive care units in a Moroccan hospital. Antimicrob Resist Infect Control. 2017;6:99. DOI:10.1186/s13756-017-0262-4; Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015 Apr;40(4):277-83.; Viehman JA, Nguyen MH, Doi Y. Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections. Drugs. 2014 Aug;74(12):1315-33. DOI:10.1007/s40265-014-0267-8; Walther-Rasmussen J, Høiby N. OXA-type carbapenemases. J Antimicrob Chemother. 2006 Mar;57(3):373-83. DOI:10.1093/jac/dki482; Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SG, Livermore DM. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006 Apr;27(4):351-3. DOI:10.1016/j.ijantimicag.2006.01.004; http://dx.doi.org/10.3205/dgkh000324; http://nbn-resolving.de/urn:nbn:de:0183-dgkh0003244; http://www.egms.de/en/journals/dgkh/2019-14/dgkh000324.shtml

الاتاحة: https://doi.org/10.3205/dgkh000324
http://nbn-resolving.de/urn:nbn:de:0183-dgkh0003244
http://www.egms.de/en/journals/dgkh/2019-14/dgkh000324.shtml

المؤلفون: Saei, AA, Yazdani, M, Lohse, SE, Bakhtiary, Z, Serpooshan, V, Ghavami, M, Asadian, M, Mashaghi, S, Dreaden, EC, Mashaghi, A, Mahmoudi, M

المصدر: CHEMISTRY OF MATERIALS. 29(16):6578-6595

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:136502407

المؤلفون: Van Vrekhem, S., Vloebergh, K., Asadian, M., Vercruysse, C., Declercq, H., Van Tongel, A., De Wilde, L., De Geyter, N., Morent, R.

المصدر: Scientific Reports ; volume 8, issue 1 ; ISSN 2045-2322

الاتاحة: http://dx.doi.org/10.1038/s41598-018-22921-6
https://www.nature.com/articles/s41598-018-22921-6
https://www.nature.com/articles/s41598-018-22921-6.pdf

المؤلفون: Asadian, M, Grande, S, Morent, R, Nikiforov, A, Declercq, H, De Geyter, N

المصدر: Journal of Physics: Conference Series ; volume 841, page 012018 ; ISSN 1742-6588 1742-6596

الاتاحة: http://dx.doi.org/10.1088/1742-6596/841/1/012018
http://stacks.iop.org/1742-6596/841/i=1/a=012018/pdf
http://stacks.iop.org/1742-6596/841/i=1/a=012018?key=crossref.65f2a7369cd3d379e7539a58b41698ea

المؤلفون: Asadian, M., Sadeghi, J., Rastegar Lari, A., Razavi, S., Hasannejad Bibalan, M., Talebi, M.

Relation: Asadian, M. and Sadeghi, J. and Rastegar Lari, A. and Razavi, S. and Hasannejad Bibalan, M. and Talebi, M. (2016) Antimicrobial resistance pattern and genetic correlation in Enterococcus faecium isolated from healthy volunteers. Microbial Pathogenesis, 92. pp. 54-59.

الاتاحة: http://eprints.iums.ac.ir/3836/
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84953449439&doi=10.1016%2fj.micpath.2015.12.014&partnerID=40&md5=089b9e5b9f28bf1c12caf18f5a92cee5

المؤلفون: Cheng, L., Ghobeira, R., Cools, P., Luthringer, B., Asadian, M., De Geyter, N., Liu, Z., Yan, K., Morent, R.

المصدر: issn:0257-8972 ; Cheng, L.; Ghobeira, R.; Cools, P.; Luthringer, B.; Asadian, M.; De Geyter, N.; Liu, Z.; Yan, K.; Morent, R.: Comparing medium pressure dielectric barrier discharge (DBD) plasmas and classic methods of surface cleaning/activation of pure Mg for biomedical applications. In: Surface and Coatings Technology. Vol. 410 (2021) 126934. (DOI: /10.1016/j.surfcoat.2021.126934.

Relation: https://dx.doi.org/10.1016/j.surfcoat.2021.126934; urn:issn:0257-8972; https://publications.hereon.de/id/39820; https://publications.hzg.de/id/39820

الاتاحة: https://publications.hereon.de/id/39820
https://publications.hzg.de/id/39820

المؤلفون: Afzal E, Zakeri S, Keyhanvar P, Bagheri M, Mahjoubi P, Asadian M, Omoomi N, Dehqanian M, Ghalandarlaki N, Darvishmohammadi T, Farjadian F, Golvajoee MS, Afzal S, Ghaffari M, Cohan RA, Grav, A, Ardestani MS

المصدر: International Journal of Nanomedicine, Vol 2013, Iss default, Pp 2943-2960 (2013)

مصطلحات موضوعية: Medicine (General), R5-920

Relation: http://www.dovepress.com/nanolipodendrosome-loaded-glatiramer-acetate-and-myogenic-differentiat-a13957; https://doaj.org/toc/1176-9114; https://doaj.org/toc/1178-2013; https://doaj.org/article/8cf9b048e91143a1aa5ff0e002c1f7bb

الاتاحة: https://doaj.org/article/8cf9b048e91143a1aa5ff0e002c1f7bb

المؤلفون: Nabipour, A., Alishahi, E., Asadian, M.

المصدر: Journal of Applied Animal Research ; volume 36, issue 2, page 195-198 ; ISSN 0971-2119 0974-1844

الاتاحة: http://dx.doi.org/10.1080/09712119.2009.9707058
http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

المؤلفون: Van Guyse J. F. R., Cools P., Egghe T., Asadian M., Vergaelen M., Rigole P., Yan W., Benetti E. M., Jerca V. -V., Declercq H., Coenye T., Morent R., Hoogenboom R., De Geyter N.

المساهمون: Van Guyse, J. F. R., Cools, P., Egghe, T., Asadian, M., Vergaelen, M., Rigole, P., Yan, W., Benetti, E. M., Jerca, V. -V., Declercq, H., Coenye, T., Morent, R., Hoogenboom, R., De Geyter, N.

مصطلحات موضوعية: 2-oxazoline, near atmospheric pressure dielectric barrier discharge, plasma polymerization, polypropylene, tissue engineering

Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000484073400093; volume:11; issue:34; firstpage:31356; lastpage:31366; numberofpages:11; journal:ACS APPLIED MATERIALS & INTERFACES; http://hdl.handle.net/11577/3416584; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85071695769

الاتاحة: http://hdl.handle.net/11577/3416584
https://doi.org/10.1021/acsami.9b09999

المؤلفون: Egghe, T., Cools, P., Guyse, J.F.R. van, Asadian, M., Khalenkow, D., Nikiforov, A., Declercq, H., Skirtach, A.G., Morent, R., Hoogenboom, R., Geyter, N. de

المصدر: ACS Applied Materials and Interfaces

Relation: lucris-id: 441265262; https://hdl.handle.net/1887/3453315

الاتاحة: https://hdl.handle.net/1887/3453315
https://doi.org/10.1021/acsami.9b19526

المؤلفون: Asadian, M.¹ (AUTHOR), Ahadpour, S.¹ (AUTHOR) Ahadpour@uma.ac.ir, Mirmasoudi, F.¹ (AUTHOR)

المصدر: Scientific Reports. 4/30/2022, Vol. 12 Issue 1, p1-9. 9p.

مصطلحات موضوعية: *HEAT engines, *QUANTUM correlations, *QUANTUM coherence, *SPIN-orbit interactions, *QUANTUM entanglement, *MAGNETIC fields, *TEMPERATURE effect

المؤلفون: Asadian, M., Sabzi, M., Anijdan, S.H. Mousavi

المصدر: International Journal of Pressure Vessels and Piping ; volume 171, page 184-193 ; ISSN 0308-0161

الاتاحة: http://dx.doi.org/10.1016/j.ijpvp.2019.02.019
https://api.elsevier.com/content/article/PII:S0308016118304757?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0308016118304757?httpAccept=text/plain

Additional Titles: Zirkulation multiresistenter Pseudomonas aeruginosa und Klebsiella pneumoniae in einem Krankenhaus für Verbrennungspatienten in Teheran, Iran

المؤلفون: Azimi, L, Alaghehbandan, R, Asadian, M, Alinejad, F, Lari, AR

المصدر: GMS Hygiene and Infection Control; VOL: 14; DOC01 /20190122/

مصطلحات الفهرس: health care-associated infection, P. aeruginosa, K. pneumoniae, antibiotic resistance, genetic relationship, pulsed-field gel electrophoresis, nosokomiale Infektion, Antibiotikaresistenz, genetische Verwandtschaft, Pulsfeld-Gel-Elektrophorese, ddc: 610, article

URL: http://nbn-resolving.de/urn:nbn:de:0183-dgkh0003173
http://www.egms.de/en/journals/dgkh/2019-14/dgkh000317.shtml
Alaghehbandan R, Azimi L, Rastegar Lari A. Nosocomial infections among burn patients in Teheran, Iran: a decade later. Ann Burns Fire Disasters. 2012 Mar 31;25(1):3-7.
Azimi L, Motevallian A, Ebrahimzadeh Namvar A, Asghari B, Lari AR. Nosocomial infections in burned patients in motahari hospital, tehran, iran. Dermatol Res Pract. 2011;2011:436952. DOI: 10.1155/2011/436952
Azimi L, Nordmann P, Lari AR, Bonnin RA. First report of OXA-48-producing Klebsiella pneumoniae strains in Iran. GMS Hyg Infect Control. 2014 Mar 7;9(1):Doc07. DOI: 10.3205/dgkh000227
Azimi L, Talebi M, Pourshafie MR, Owlia P, Rastegar Lari A. Characterization of Carbapenemases in Extensively Drug Resistance Acinetobacter baumannii in a Burn Care Center in Iran. Int J Mol Cell Med. 2015;4(1):46-53.
Azimi L, Talebi M, Owlia P, Rastegar-Lari A. Investigated of ampC in Carbapenem Resistant Gram-Negative Bacteria Isolated from Burned Patients. J Med Bacteriol. 2014;3(3-4):20-5.
Beheshti S, Zia M. Bacteriology of burns and antibiogram in an Iranian burn care center. Afr J Pharm Pharmacol. 2011;5(4):538-41. DOI: 10.5897/AJPP10.375
Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: nineteenth informational supplement M100-S21. Wayne, PA: CLSI; 2013.
Fazeli H, Akbari R, Moghim S, Narimani T, Arabestani MR, Ghoddousi AR. Pseudomonas aeruginosa infections in patients, hospital means, and personnel's specimens. J Res Med Sci. 2012 Apr;17(4):332-7.
Finnan S, Morrissey JP, O'Gara F, Boyd EF. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment. J Clin Microbiol. 2004 Dec;42(12):5783-92. DOI: 10.1128/JCM.42.12.5783-5792.2004
Lanini S, D'Arezzo S, Puro V, Martini L, Imperi F, Piselli P, Montanaro M, Paoletti S, Visca P, Ippolito G. Molecular epidemiology of a Pseudomonas aeruginosa hospital outbreak driven by a contaminated disinfectant-soapdispenser. PLoS One. 2011 Feb 16;6(2):e17064. DOI: 10.1371/journal.pone.0017064
Lari AR, Alaghehbandan R. Nosocomial infections in an Iranian burn care center. Burns. 2000 Dec;26(8):737-40. DOI: 10.1016/S0305-4179(00)00048-6
Lari AR, Azimi L, Soroush S, Taherikalani M. Low prevalence of metallo-beta-lactamase in Pseudomonas aeruginosa isolated from a tertiary burn care center in Tehran. Int J Immunopathol Pharmacol. 2015 Sep;28(3):384-9. DOI: 10.1177/0394632015578343
Naze F, Jouen E, Randriamahazo RT, Simac C, Laurent P, Blériot A, Chiroleu F, Gagnevin L, Pruvost O, Michault A. Pseudomonas aeruginosa outbreak linked to mineral water bottles in a neonatal intensive care unit: fast typing by use of high-resolution melting analysis of a variable-number tandem-repeat locus. J Clin Microbiol. 2010 Sep;48(9):3146-52. DOI: 10.1128/JCM.00402-10
Petit SM, Lavenir R, Colinon-Dupuich C, Boukerb AM, Cholley P, Bertrand X, Freney J, Doléans-Jordheim A, Nazaret S, Laurent F, Cournoyer B. Lagooning of wastewaters favors dissemination of clinically relevant Pseudomonas aeruginosa. Res Microbiol. 2013 Oct;164(8):856-66. DOI: 10.1016/j.resmic.2013.06.007
Rastegar Lari A, Azimi L, Rahbar M, Fallah F, Alaghehbandan R. Phenotypic detection of Klebsiella pneumoniae carbapenemase among burns patients: first report from Iran. Burns. 2013 Feb;39(1):174-6. DOI: 10.1016/j.burns.2012.02.025
Salimi H, Yakhchali B, Owlia P. Molecular epidemiology and drug susceptibility of Pseudomonas aeruginosa strains isolated from burn patients. Lab Med. 2010;41(9):540-4. DOI: 10.1309/LMNIJE31EDC1WAMP
Salimi H, Owlia P, Yakhchali B, Martini L. Characterization of Pseudomonas aeruginosain burn patients using PCR- restriction fragment length polymorphism and random amplified polymorphic DNA analysis. Iran J Med Sci. 2010;35(3):236-41.
Tofteland S, Naseer U, Lislevand JH, Sundsfjord A, Samuelsen O. A long-term low-frequency hospital outbreak of KPC-producing Klebsiella pneumoniae involving Intergenus plasmid diffusion and a persisting environmental reservoir. PLoS ONE. 2013;8(3):e59015. DOI: 10.1371/journal.pone.0059015
Voulgari E, Zarkotou O, Ranellou K, Karageorgopoulos DE, Vrioni G, Mamali V, Themeli-Digalaki K, Tsakris A. Outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in Greece involving an ST11 clone. J Antimicrob Chemother. 2013 Jan;68(1):84-8. DOI: 10.1093/jac/dks356
Zanetti G, Blanc DS, Federli I, Raffoul W, Petignat C, Maravic P, Francioli P, Berger MM. Importation of Acinetobacter baumannii into a burn unit: a recurrent outbreak of infection associated with widespread environmental contamination. Infect Control Hosp Epidemiol. 2007 Jun;28(6):723-5. DOI: 10.1086/517956

Additional Titles: Testung der Kombination von Tazobactam mit Meropenem und Ciprofloxacin auf synergistische Wirkung gegen multiresistente Acinetobacter baumannii Isolate von Verbrennungspatienten in Teheran

المؤلفون: Valadan Tahbaz, S, Azimi, L, Asadian, M, Lari, AR

المصدر: GMS Hygiene and Infection Control; VOL: 14; DOC08 /20190802/

مصطلحات الفهرس: Acinetobacter baumannii, tazobactam, MIC, carbapenem resistance, Tazobactam, Carbapenemeresistenz, ddc: 610, article

URL: http://nbn-resolving.de/urn:nbn:de:0183-dgkh0003244
http://www.egms.de/en/journals/dgkh/2019-14/dgkh000324.shtml
An JH, Kim YH, Moon JE, Jeong JH, Kim SH, Kang SJ, Park KH, Jung SI, Jang HC. Active surveillance for carbapenem-resistant Acinetobacter baumannii in a medical intensive care unit: Can it predict and reduce subsequent infections and the use of colistin? Am J Infect Control. 2017 Jun;45(6):667-72. DOI: 10.1016/j.ajic.2017.01.016
Barnaud G, Zihoune N, Ricard JD, Hippeaux MC, Eveillard M, Dreyfuss D, Branger C. Two sequential outbreaks caused by multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 or OXA-72 oxacillinase in an intensive care unit in France. J Hosp Infect. 2010 Dec;76(4):358-60. DOI: 10.1016/j.jhin.2010.05.026
Chagas TP, Carvalho KR, de Oliveira Santos IC, Carvalho-Assef AP, Asensi MD. Characterization of carbapenem-resistant Acinetobacter baumannii in Brazil (2008-2011): countrywide spread of OXA-23-producing clones (CC15 and CC79). Diagn Microbiol Infect Dis. 2014 Aug;79(4):468-72. DOI: 10.1016/j.diagmicrobio.2014.03.006
Chen Y, Gao J, Zhang H, Ying C. Spread of the bla(OXA-23)-Containing Tn2008 in Carbapenem-Resistant Acinetobacter baumannii Isolates Grouped in CC92 from China. Front Microbiol. 2017 Feb 6;8:163. DOI: 10.3389/fmicb.2017.00163
Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev. 2006 Apr;19(2):403-34. DOI: 10.1128/CMR.19.2.403-434.2006
Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: nineteenth informational supplement M100-S21. 2018.
Coban YK. Infection control in severely burned patients. World J Crit Care Med. 2012 Aug;1(4):94-101. DOI: 10.5492/wjccm.v1.i4.94
Codjoe FS, Donkor ES. Carbapenem Resistance: A Review. Med Sci (Basel). 2017 Dec 21;6(1):1. DOI: 10.3390/medsci6010001
Deveci Ö, Dal T, Tekin R, Bozkurt F, Tekin A, Dayan S. Carbapenem resistance in Acinetobacter baumannii: where is it heading? Infez Med. 2013 Sep;21(3):211-5. DOI: 0.5455/medscience.2014.03.8124
Douraghi M, Jasemi S, Kodori M, Rahbar M, Boroumand MA. Evidence of Interruption of the comM Gene in a Large Series of Clinical Isolates of Multidrug-Resistant Acinetobacter baumannii. J Mol Microbiol Biotechnol. 2016;26(6):410-413. DOI: 10.1159/000448785
de Souza Gusatti C, Bertholdo LM, Otton LM, Marchetti DP, Ferreira AE, Corção G. First occurrence of bla OXA-58 in Acinetobacter baumannii isolated from a clinical sample in Southern Brazil. Braz J Microbiol. 2012 Jan;43(1):243-6. DOI: 10.1590/S1517-838220120001000027
Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005 May;40(9):1333-41. DOI: 10.1086/429323
Farsiani H, Mosavat A, Soleimanpour S, Nasab MN, Salimizand H, Jamehdar SA, Ghazvini K, Aryan E, Baghani AA. Limited genetic diversity and extensive antimicrobial resistance in clinical isolates of Acinetobacter baumannii in north-east Iran. J Med Microbiol. 2015 Jul;64(7):767-73. DOI: 10.1099/jmm.0.000090
Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006 Mar;42(5):692-9. DOI: 10.1086/500202
Fu Y, Jiang J, Zhou H, Jiang Y, Fu Y, Yu Y, Zhou J. Characterization of a novel plasmid type and various genetic contexts of bla OXA-58 in Acinetobacter spp. from multiple cities in China. PLoS ONE. 2014;9(1):e84680. DOI: 10.1371/journal.pone.0084680
Hasan B, Perveen K, Olsen B, Zahra R. Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan. J Med Microbiol. 2014 Jan;63(Pt 1):50-5. DOI: 10.1099/jmm.0.063925-0
Héritier C, Poirel L, Lambert T, Nordmann P. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother. 2005 Aug;49(8):3198-202. DOI: 10.1128/AAC.49.8.3198-3202.2005
Jeon BC, Jeong SH, Bae IK, Kwon SB, Lee K, Young D, Lee JH, Song JS, Lee SH. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in korea. J Clin Microbiol. 2005 May;43(5):2241-5. DOI: 10.1128/JCM.43.5.2241-2245.2005
Jung SY, Lee SH, Lee SY, Yang S, Noh H, Chung EK, Lee JI. Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: a systemic review and Bayesian network meta-analysis. Crit Care. 2017 Dec;21(1):319. DOI: 10.1186/s13054-017-1916-6
Kiffer CR, Sampaio JL, Sinto S, Oplustil CP, Koga PC, Arruda AC, Turner PJ, Mendes C. In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii. Diagn Microbiol Infect Dis. 2005 Aug;52(4):317-22. DOI: 10.1016/j.diagmicrobio.2005.03.003
Lin MF, Lan CY. Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside. World J Clin Cases. 2014 Dec;2(12):787-814. DOI: 10.12998/wjcc.v2.i12.787
Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012 Mar;18(3):268-81. DOI: 10.1111/j.1469-0691.2011.03570.x
Manchanda V, Sanchaita S, Singh N. Multidrug resistant acinetobacter. J Glob Infect Dis. 2010 Sep;2(3):291-304. DOI: 10.4103/0974-777X.68538
Marie MA, Krishnappa LG, Alzahrani AJ, Mubaraki MA, Alyousef AA. A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii. Bosn J Basic Med Sci. 2015 Oct;15(4):24-9. DOI: 10.17305/bjbms.2015.526
Marqué S, Poirel L, Héritier C, Brisse S, Blasco MD, Filip R, Coman G, Naas T, Nordmann P. Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. J Clin Microbiol. 2005 Sep;43(9):4885-8. DOI: 10.1128/JCM.43.9.4885-4888.2005
Mohammadi F, Goudarzi H, Hashemi A, Nojookambari NY, Khoshnood S, Sabzehali F. Detection of ISAba1 in Acinetobacter baumannii strains carrying OXA genes isolated from iranian burns patients. Arch Ped Infect Dis. 2017 April;5(2):e39307.
Munita JM, Arias CA. Mechanisms of Antibiotic Resistance. Microbiol Spectr. 2016 04;4(2):. DOI: 10.1128/microbiolspec.VMBF-0016-2015
Nowak J, Zander E, Stefanik D, Higgins PG, Roca I, Vila J, McConnell MJ, Cisneros JM, Seifert H; MagicBullet Working Group WP4. High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial. J Antimicrob Chemother. 2017 Dec;72(12):3277-82. DOI: 10.1093/jac/dkx322
Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. Carbapenems: past, present, and future. Antimicrob Agents Chemother. 2011 Nov;55(11):4943-60. DOI: 10.1128/AAC.00296-11
Rezaei A, Fazeli H, Moghadampour M, Halaji M, Faghri J. Determination of antibiotic resistance pattern and prevalence of OXA-type carbapenemases among Acinetobacter baumannii clinical isolates from inpatients in Isfahan, central Iran. Infez Med. 2018 Mar;26(1):61-66.
Rynga D, Shariff M, Deb M. Phenotypic and molecular characterization of clinical isolates of Acinetobacter baumannii isolated from Delhi, India. Ann Clin Microbiol Antimicrob. 2015 Sep;14:40. DOI: 10.1186/s12941-015-0101-5
Sahuquillo-Arce J, Hernández-Cabezas A, Yarad-Auad F, Ibáñez-Martínez E, Falomir-Salcedo P, Ruiz-Gaitán A. Carbapenemases: A worldwide threat to antimicrobial therapy. World J Pharmacol. 2015;4(1):75-95. DOI: 10.5497/wjp.v4.i1.75
Salehi B, Goudarzi H, Nikmanesh B, Houri H, Alavi-Moghaddam M, Ghalavand Z. Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran. J Infect Chemother. 2018 Jul;24(7):515-523. DOI: 10.1016/j.jiac.2018.02.009
Sirijatuphat R, Thamlikitkul V. Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections. Antimicrob Agents Chemother. 2014 Sep;58(9):5598-601. DOI: 10.1128/AAC.02435-13
Sohrabi N, Farajnia S, Akhi MT, Nahaei MR, Naghili B, Peymani A, Amiri Z, Rezaee MA, Saeedi N. Prevalence of OXA-type beta-lactamases among Acinetobacter baumannii isolates from Northwest of Iran. Microb Drug Resist. 2012 Aug;18(4):385-9. DOI: 10.1089/mdr.2011.0077
Taherikalani M, Fatolahzadeh B, Emaneini M, Soroush S, Feizabadi MM. Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals. New Microbiol. 2009 Jul;32(3):265-71.
Tekin R, Dal T, Bozkurt F, Deveci O, Palanc Y, Arslan E, Selçuk CT, Hosoglu S. Risk factors for nosocomial burn wound infection caused by multidrug resistant Acinetobacter baumannii. J Burn Care Res. 2014 Jan-Feb;35(1):e73-80. DOI: 10.1097/BCR.0b013e31828a493f
Temocin F, Erdinc FS, Tulek N, Demirelli M, Ertem G, Kinikli S, Koksal E. Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii. Braz J Microbiol. 2015 Oct-Dec;46(4):1119-24. DOI: 10.1590/S1517-838246420140101
Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, Pitt TL. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett. 2006 May;258(1):72-7. DOI: 10.1111/j.1574-6968.2006.00195.x
Uwingabiye J, Lemnouer A, Roca I, Alouane T, Frikh M, Belefquih B, Bssaibis F, Maleb A, Benlahlou Y, Kassouati J, Doghmi N, Bait A, Haimeur C, Louzi L, Ibrahimi A, Vila J, Elouennass M. Clonal diversity and detection of carbapenem resistance encoding genes among multidrug-resistant isolates recovered from patients and environment in two intensive care units in a Moroccan hospital. Antimicrob Resist Infect Control. 2017;6:99. DOI: 10.1186/s13756-017-0262-4
Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015 Apr;40(4):277-83.
Viehman JA, Nguyen MH, Doi Y. Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections. Drugs. 2014 Aug;74(12):1315-33. DOI: 10.1007/s40265-014-0267-8
Walther-Rasmussen J, Høiby N. OXA-type carbapenemases. J Antimicrob Chemother. 2006 Mar;57(3):373-83. DOI: 10.1093/jac/dki482
Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SG, Livermore DM. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006 Apr;27(4):351-3. DOI: 10.1016/j.ijantimicag.2006.01.004

المؤلفون: Asadian, M. H.¹ mh.asadian@iauba.ac.ir, Molaei, M. R.¹ mrmolaei@uk.ac.ir

المصدر: Journal of Mathematical Extension. 2020, Vol. 14 Issue 3, p97-115. 19p.

مصطلحات موضوعية: *FUNCTION spaces, *UNCERTAINTY, *FUZZY sets, *DYNAMICAL systems, *PARTITIONS (Mathematics)

المؤلفون: Asadian, M., Saeedi, H.

المصدر: Journal of Crystal Growth ; volume 435, page 68-75 ; ISSN 0022-0248

الاتاحة: http://dx.doi.org/10.1016/j.jcrysgro.2015.11.017
https://api.elsevier.com/content/article/PII:S0022024815006776?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0022024815006776?httpAccept=text/plain